Haramaki M[Author] - Search Results

Year	Number of Results
1992	2
1993	2
1994	1
1995	1
1996	2
1997	1
1998	1
1999	2
2004	1
2006	1
2022	0

1

Expression of CD44 in human hepatocellular carcinoma cell lines.

Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M. Haramaki M, et al. Hepatology. 1995 May;21(5):1276-84. Hepatology. 1995. PMID: 7537711

2

Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines.

Yano H, Fukuda K, Haramaki M, Momosaki S, Ogasawara S, Higaki K, Kojiro M. Yano H, et al. Among authors: haramaki m. J Hepatol. 1996 Oct;25(4):454-64. doi: 10.1016/s0168-8278(96)80204-2. J Hepatol. 1996. PMID: 8912144

3

A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP.

Murashima S, Tanaka M, Haramaki M, Yutani S, Nakashima Y, Harada K, Ide T, Kumashiro R, Sata M. Murashima S, et al. Among authors: haramaki m. Dig Dis Sci. 2006 Apr;51(4):808-12. doi: 10.1007/s10620-006-3211-2. Dig Dis Sci. 2006. PMID: 16615008

4

Incidence of hepatitis D virus infection in Japanese patients with hepatocellular carcinoma--immunohistochemical investigation of the delta antigen.

Kage M, Kosai K, Shimamatsu K, Nakashima O, Haramaki M, Yasunaga M, Iha H, Kojiro M, Govindarajan S. Kage M, et al. Among authors: haramaki m. Kurume Med J. 1992;39(4):231-4. doi: 10.2739/kurumemedj.39.231. Kurume Med J. 1992. PMID: 1339069 Free article.

5

Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.

Hisaka T, Yano H, Haramaki M, Utsunomiya I, Kojiro M. Hisaka T, et al. Among authors: haramaki m. Int J Oncol. 1999 Mar;14(3):453-60. doi: 10.3892/ijo.14.3.453. Int J Oncol. 1999. PMID: 10024677

6

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.

Yano H, Iemura A, Haramaki M, Ogasawara S, Takayama A, Akiba J, Kojiro M. Yano H, et al. Among authors: haramaki m. Hepatology. 1999 Jun;29(6):1708-17. doi: 10.1002/hep.510290624. Hepatology. 1999. PMID: 10347112

7

The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase.

Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M. Yano H, et al. Among authors: haramaki m. Cancer Res. 1994 Jan 15;54(2):448-54. Cancer Res. 1994. PMID: 8275481

8

Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells.

Yano H, Iemura A, Fukuda K, Mizoguchi A, Haramaki M, Kojiro M. Yano H, et al. Among authors: haramaki m. Hepatology. 1993 Aug;18(2):320-7. Hepatology. 1993. PMID: 8393423

9

A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.

Yano H, Iemura A, Haramaki M, Momosaki S, Ogasawara S, Higaki K, Kojiro M. Yano H, et al. Among authors: haramaki m. J Hepatol. 1996 Apr;24(4):413-22. doi: 10.1016/s0168-8278(96)80161-9. J Hepatol. 1996. PMID: 8738727

10

Ultrastructural studies of the bile duct in alcoholic liver disease.

Kage M, Kosai K, Shimamatsu K, Kojiro M, Haramaki M, Yasunaga M, Iha H, Harada A. Kage M, et al. Among authors: haramaki m. Kurume Med J. 1992;39(4):219-29. doi: 10.2739/kurumemedj.39.219. Kurume Med J. 1992. PMID: 1305905 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results